Veracyte Return on Tangible Equity 2012-2023 | VCYT

Current and historical return on tangible equity values for Veracyte (VCYT) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Veracyte Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2023-12-31 $-0.07B $0.25B -32.17%
2023-09-30 $-0.05B $0.24B -22.96%
2023-06-30 $-0.03B $0.22B -13.99%
2023-03-31 $-0.03B $0.21B -15.50%
2022-12-31 $-0.04B $0.20B -19.12%
2022-09-30 $-0.04B $0.20B -23.28%
2022-06-30 $-0.05B $0.19B -26.34%
2022-03-31 $-0.05B $0.19B -21.38%
2021-12-31 $-0.08B $0.19B -28.87%
2021-09-30 $-0.07B $0.18B -23.82%
2021-06-30 $-0.06B $0.34B -17.97%
2021-03-31 $-0.07B $0.34B -21.33%
2020-12-31 $-0.04B $0.36B -13.42%
2020-09-30 $-0.03B $0.36B -15.89%
2020-06-30 $-0.03B $0.16B -17.32%
2020-03-31 $-0.02B $0.16B -11.47%
2019-12-31 $-0.01B $0.17B -7.12%
2019-09-30 $-0.01B $0.22B -5.62%
2019-06-30 $-0.01B $0.21B -10.58%
2019-03-31 $-0.02B $0.07B -27.78%
2018-12-31 $-0.02B $0.07B -54.66%
2018-09-30 $-0.03B $0.07B -92.31%
2018-06-30 $-0.03B $0.01B -151.90%
2018-03-31 $-0.03B $0.02B -124.00%
2017-12-31 $-0.03B $0.02B -98.36%
2017-09-30 $-0.03B $0.03B -72.73%
2017-06-30 $-0.03B $0.03B -76.92%
2017-03-31 $-0.03B $0.04B -100.87%
2016-12-31 $-0.03B $0.04B -119.23%
2016-09-30 $-0.04B $0.02B -147.37%
2016-06-30 $-0.04B $0.02B -125.62%
2016-03-31 $-0.04B $0.03B -95.36%
2015-12-31 $-0.03B $0.04B -95.77%
2015-09-30 $-0.03B $0.04B -103.82%
2015-06-30 $-0.03B $0.05B -109.09%
2015-03-31 $-0.03B $0.02B -105.08%
2014-12-31 $-0.03B $0.02B -80.00%
2014-09-30 $-0.03B $0.03B -61.54%
2014-06-30 $-0.03B $0.05B -67.97%
2014-03-31 $-0.03B $0.05B -86.21%
2013-12-31 $-0.03B $0.06B -151.52%
2013-06-30 $-0.02B $0.01B -900.00%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.454B $0.361B
Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $212.947B 25.90
Intuitive Surgical (ISRG) United States $133.755B 83.49
Edwards Lifesciences (EW) United States $53.692B 35.54
DexCom (DXCM) United States $51.875B 89.11
IQVIA Holdings (IQV) United States $41.956B 24.88
IDEXX Laboratories (IDXX) United States $40.804B 48.79
Alcon (ALC) Switzerland $39.985B 29.49
STERIS (STE) Ireland $19.882B 23.53
Waters (WAT) United States $18.955B 27.20
Hologic (HOLX) United States $18.201B 20.09
SONOVA HOLDING (SONVY) Switzerland $16.648B 0.00
ShockWave Medical (SWAV) United States $12.233B 84.52
Fresenius Medical Care AG KGaA (FMS) Germany $11.015B 13.60
Teleflex (TFX) United States $9.922B 15.58
Sysmex ADR (SSMXY) Japan $9.881B 30.99
Penumbra (PEN) United States $8.135B 100.57
Masimo (MASI) United States $7.308B 40.98
Globus Medical (GMED) United States $7.015B 22.24
Glaukos (GKOS) United States $4.791B 0.00
Integer Holdings (ITGR) United States $3.975B 25.41
TransMedics (TMDX) United States $3.004B 0.00
LivaNova (LIVN) United Kingdom $2.880B 18.99
Elekta AB (EKTAY) Sweden $2.720B 18.66
PROCEPT BioRobotics (PRCT) United States $2.579B 0.00
Integra LifeSciences Holdings (IART) United States $2.520B 10.34
Nihon Kohden (NHNKY) Japan $2.341B 19.80
Inari Medical (NARI) United States $2.289B 394.90
Tandem Diabetes Care (TNDM) United States $2.057B 0.00
RxSight (RXST) United States $1.970B 0.00
Alphatec Holdings (ATEC) United States $1.808B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.871B 16.11
OPKO Health (OPK) United States $0.857B 0.00
Artivion (AORT) United States $0.838B 96.90
Paragon 28 (FNA) United States $0.815B 0.00
Pacific Biosciences Of California (PACB) United States $0.760B 0.00
Treace Medical Concepts (TMCI) United States $0.734B 0.00
OrthoPediatrics (KIDS) United States $0.724B 0.00
Silk Road Medical (SILK) United States $0.707B 0.00
SiBone (SIBN) United States $0.627B 0.00
Mesa Laboratories (MLAB) United States $0.563B 19.13
IRadimed (IRMD) United States $0.518B 30.06
ORTHOFIX MEDICAL INC (OFIX) United States $0.490B 0.00
Nevro (NVRO) United States $0.458B 0.00
Pulse Biosciences (PLSE) United States $0.432B 0.00
CVRx (CVRX) United States $0.359B 0.00
NeuroPace (NPCE) United States $0.352B 0.00
Tactile Systems Technology (TCMD) United States $0.335B 11.28
AxoGen (AXGN) United States $0.307B 0.00
EDAP TMS S.A (EDAP) France $0.276B 0.00
Sight Sciences (SGHT) United States $0.274B 0.00
AngioDynamics (ANGO) United States $0.253B 0.00
Accuray (ARAY) United States $0.229B 0.00
Atossa Genetics (ATOS) United States $0.214B 0.00
Alpha Tau Medical (DRTS) Israel $0.194B 0.00
908 Devices (MASS) United States $0.191B 0.00
Semler Scientific (SMLR) United States $0.181B 9.77
Inogen (INGN) United States $0.167B 0.00
ClearPoint Neuro (CLPT) United States $0.152B 0.00
Neuronetics (STIM) United States $0.125B 0.00
Delcath Systems (DCTH) United States $0.124B 0.00
Envoy Medical (COCH) United States $0.119B 0.00
Yubo Biotech (YBGJ) China $0.112B 0.00
KORU Medical Systems (KRMD) United States $0.095B 0.00
Spectral Diagnostics (EDTXF) Canada $0.090B 0.00
Monogram Orthopaedics (MGRM) United States $0.082B 0.00
Hyperfine (HYPR) United States $0.072B 0.00
EnVVeno Medical (NVNO) United States $0.066B 0.00
SEP Acquisition (SEPA) United States $0.056B 0.00
Autonomix Medical (AMIX) United States $0.055B 0.00
InspireMD (NSPR) Israel $0.053B 0.00
Sensus Healthcare (SRTS) United States $0.052B 106.67
Vicarious Surgical (RBOT) United States $0.052B 0.00
Vasomedical (VASO) United States $0.051B 9.13
ReWalk Robotics (LFWD) Israel $0.043B 0.00
Aspira Women's Health (AWH) United States $0.042B 0.00
Rapid Micro Biosystems (RPID) United States $0.041B 0.00
Lucid Diagnostics (LUCD) United States $0.039B 0.00
LENSAR (LNSR) United States $0.036B 0.00
Pixie Dust Technologies (PXDT) Japan $0.035B 0.00
Spectral AI (MDAI) United States $0.035B 0.00
DarioHealth (DRIO) United States $0.034B 0.00
Precision Optics (POCI) United States $0.033B 0.00
Ekso Bionics Holdings (EKSO) United States $0.026B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.024B 0.00
QT Imaging Holdings (QTI) United States $0.023B 0.00
Accelerate Diagnostics (AXDX) United States $0.020B 0.00
PAVmed (PAVM) United States $0.018B 0.00
T2 Biosystems (TTOO) United States $0.016B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
Biosig Technologies (BSGM) United States $0.010B 0.00
Avinger (AVGR) United States $0.006B 0.00
Helius Medical Technologies (HSDT) United States $0.005B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00